Editorial: Percutaneous placement of a permanent tunnelled catheter for patients with non-malignant ascites—Is it safe?
Publikation: Bidrag til tidsskrift › Leder › Forskning › fagfællebedømt
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Alimentary Pharmacology and Therapeutics |
| Vol/bind | 56 |
| Udgave nummer | 5 |
| Sider (fra-til) | 909-910 |
| Antal sider | 2 |
| ISSN | 0269-2813 |
| DOI | |
| Status | Udgivet - 2022 |
Bibliografisk note
Funding Information:
Dr Gluud research funding from Novo Nordisk, Alexion, Gilead, Vingmed and honoraria as consultant/speaker/expert testimony from Novo Nordisk, Pfizer, Sobi International, and Norgine. Dr Kimer speaker, Norgine. Dr Møller, none declared. Declaration of personal interests:
ID: 320656415